These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 35602017)

  • 1. Bacterial Outer Membrane Permeability Increase Underlies the Bactericidal Effect of Fatty Acids From
    Mohamed H; Marusich E; Afanasev Y; Leonov S
    Front Microbiol; 2022; 13():844811. PubMed ID: 35602017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty Acids-Enriched Fractions of
    Mohamed H; Marusich E; Afanasev Y; Leonov S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445533
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
    Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
    Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty Acids from
    Marusich E; Mohamed H; Afanasev Y; Leonov S
    Microorganisms; 2020 Sep; 8(9):. PubMed ID: 32948050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
    Sader HS; Castanheira M; Flamm RK
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates].
    Hoşbul T; Aydoğan CN; Kaya S; Bedir O; Gümral R; Albay A
    Mikrobiyol Bul; 2022 Apr; 56(2):218-229. PubMed ID: 35477226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NDM-1 Carbapenemase-Producing Enterobacteriaceae are Highly Susceptible to Ceragenins CSA-13, CSA-44, and CSA-131.
    Chmielewska SJ; Skłodowski K; Piktel E; Suprewicz Ł; Fiedoruk K; Daniluk T; Wolak P; Savage PB; Bucki R
    Infect Drug Resist; 2020; 13():3277-3294. PubMed ID: 33061475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Draft genome sequence of a carbapenemase-producing (NDM-1) and multidrug-resistant, hypervirulent Klebsiella pneumoniae ST11 isolate from Pakistan, with a non-hypermucoviscous phenotype associated with rmpA2 mutation.
    Imtiaz W; Dasti JI; Andrews SC
    J Glob Antimicrob Resist; 2021 Jun; 25():359-362. PubMed ID: 33991746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains.
    Morici P; Florio W; Rizzato C; Ghelardi E; Tavanti A; Rossolini GM; Lupetti A
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1739-1748. PubMed ID: 28470337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect and antibiofilm activity of the antimicrobial peptide K11 with conventional antibiotics against multidrug-resistant and extensively drug-resistant
    Chatupheeraphat C; Peamchai J; Luk-In S; Eiamphungporn W
    Front Cell Infect Microbiol; 2023; 13():1153868. PubMed ID: 37113135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Antimicrobial Potential and Stability of Black Soldier Fly
    Zabulionė A; Šalaševičienė A; Makštutienė N; Šarkinas A
    Gels; 2023 Oct; 9(10):. PubMed ID: 37888366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles.
    van der Weide H; Vermeulen-de Jongh DMC; van der Meijden A; Boers SA; Kreft D; Ten Kate MT; Falciani C; Pini A; Strandh M; Bakker-Woudenberg IAJM; Hays JP; Goessens WHF
    Int J Antimicrob Agents; 2019 Aug; 54(2):159-166. PubMed ID: 31173867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the in vitro activity of ceftazidime/avibactam against a global collection of multidrug-resistant Klebsiella spp. from the INFORM surveillance programme (2015-2017).
    Rossolini GM; Stone GG
    Int J Antimicrob Agents; 2020 Sep; 56(3):106111. PubMed ID: 32721602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains.
    Erdem F; Abulaila A; Aktas Z; Oncul O
    Antimicrob Resist Infect Control; 2020 May; 9(1):70. PubMed ID: 32430058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Cecropin D-Derived Short Cationic Antimicrobial Peptide Exhibits Antibacterial Activity Against Wild-Type and Multidrug-Resistant Strains of
    Ocampo-Ibáñez ID; Liscano Y; Rivera-Sánchez SP; Oñate-Garzón J; Lugo-Guevara AD; Flórez-Elvira LJ; Lesmes MC
    Evol Bioinform Online; 2020; 16():1176934320936266. PubMed ID: 32636607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
    Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
    Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial and antibiofilm activity of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-1H pyrazoles and thiazoles in multidrug-resistant pathogens.
    da Cunha KF; de Oliveira Garcia M; Allend SO; de Albernaz DTF; da Rosa BN; Pereira IL; de Pereira de Pereira CM; Hartwig DD
    Braz J Microbiol; 2023 Dec; 54(4):2587-2595. PubMed ID: 37656404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of multidrug-resistant (MDR) Klebsiella pneumoniae harboring several β-lactamase and integron genes collected from several hospitals in the north of Iran.
    Farhadi M; Ahanjan M; Goli HR; Haghshenas MR; Gholami M
    Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):70. PubMed ID: 34583687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on MICs of Tigecycline in Clinical Isolates of Carbapenem Resistant Enterobacteriaceae (CRE) at a Tertiary Care Centre in North India.
    Khare V; Gupta P; Haider F; Begum R
    J Clin Diagn Res; 2017 Mar; 11(3):DC18-DC21. PubMed ID: 28511383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of ComASP™ Colistin (formerly SensiTest™ Colistin), a commercial broth microdilution-based method to evaluate the colistin minimum inhibitory concentration for carbapenem-resistant Klebsiella pneumoniae isolates.
    Galani I; Adamou P; Karaiskos I; Giamarellou H; Souli M
    J Glob Antimicrob Resist; 2018 Dec; 15():123-126. PubMed ID: 30036693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.